Company Profile - Zeria Pharmaceutical Co Ltd
Introduction
Zeria Pharmaceutical Co Ltd (Zeria), formerly Zeria Yakusho Kenkyusho Co Ltd, manufactures and distributes pharmaceutical and consumer health care products.The company’s pharmaceutical product range includes drugs for the treatment of ulcerative colitis, Crohn’s disease, functional dyspepsia, gastritis and ulcers and other gastrointestinal diseases. It offers combination granules, calcium channel blockers, anti-leukopenia and iron deficiency anemia agents. Zeria also markets OTC drugs for arthralgia and lumbalgia, physical fatigue and exhaustion and soft drinks. The company owns and operate production facilities in the Switzerland, Denmark, Japan and Vietnam. Zeria is headquartered in Chuo-Ku, Tokyo, Japan.
Company info
Country (HQ): | Japan |
Sector: | Pharmaceuticals and Healthcare |
Market Cap (US$ m): | 994 |
Revenue (US$ m): | 505 (2023) |
Innovation ranking
Innovation score
Closest peers in the Pharmaceuticals and Healthcare sector
Innovation Ranking
Johnson & Johnson
United States
Pharmaceuticals and Healthcare
F. Hoffmann-La Roche Ltd
Switzerland
Pharmaceuticals and Healthcare
Zeria Pharmaceutical Co Ltd
Japan
Pharmaceuticals and Healthcare
EyeGate Pharmaceuticals Inc
United States
Pharmaceuticals and Healthcare
Shin Poong Pharm Co Ltd
South Korea
Pharmaceuticals and Healthcare
Are you ranked? Get the Innovation Ranking Report
-
Company Ranking Report
- If your company is ranked you can get more detailed information about your ranking through the Innovation Ranking Report
- Full company scorecard across the 3 pillars and 19 data indicators that make up the ranking score
- Contextualised information on the company's standing in relation to peers
- Key takeaways on the company's position in its sector, country and its standing in relation to key industry themes
- Tips on how to use your ranking to tell a unique and compelling story in your marketing, benchmarking and hiring processes
- Rosettes
- Certificate of Achievement
- Press release